Asia-Pacific Malaria Treatment Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 198
  • No of Figures: 49

Asia-Pacific Malaria Treatment Market, By Agent (Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae and P. Knowlelsi), Type (Medication and Vaccination), Treatment Type (Suppressive Treatment and Radical Treatment), Drug Type (Branded and Generics), Route of Administration (Oral and Parenteral), End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Malaria Treatment Market

Market Analysis and Insights : Asia-Pacific Malaria Treatment Market

The malaria treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.8% in the forecast period of 2020 to 2027 and is expected to reach USD 1,07,492.89 thousand by 2027 from USD 69,036.10 thousand in 2019. Increasing incidence of malaria vecto-borne diseases, growing demand for advanced malaria treatment products are the major drivers for the growth of the market in the forecast period.

The malaria treatment market is growing tremendously across Asia-Pacific due to the rise in medical insurance and additionally pandemic outbreak of coronavirus disease (COVID-19) across the globe. The various categories of the medication for malaria treatment include chloroquine, mefloquine, quinine, primaquine, hydroxychloroquine, artemisinin-based combination therapy (ACT), non-artemisinin based combinations (non-acts) and others. The presence of wide range of malaria medication treatment products is providing the better patient experience with reducing the risk of death. The increased research and development activities lead to the increased product launch by key market players of the malaria treatment market. However adverse effects and risks associated with anti-malaria may hamper the future growth of malaria treatment market.

The agreement and acquisition is the golden opportunity for the malaria treatment market players to elevate their revenue growth. It is predicted that poor accessibility of malaria treatments products is the major key challenge for the future growth of malaria treatment market.

The malaria treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the malaria treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Malaria Treatment Market

Malaria Treatment Market Scope and Market Size

The malaria treatment market is categorized into seven notable segments which are based on the agent, type, treatment type, drug type, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core influencing areas and the difference in your target markets.

  • On the basis of agent, the malaria treatment market is segmented into plasmodium falciparum, P. vivax, P. ovale, P. malariae and P. knowlelsi. In 2020, plasmodium falciparum segment is dominating the malaria treatment market due to its rapid transmission. Additionally, climate condition and humidity of Sub-Saharan Africa is enhancing the transmission of malaria by the virtue of plasmodium falciparum.
  • On the basis of type, the malaria treatment market is segmented into medication and vaccination. In 2020, vaccination segment is dominating the malaria treatment market due to its cost effective, easily accessible and is a primarily treatment for the malaria patient pool.
  • On the basis of treatment type, the malaria treatment market is segmented into suppressive treatment and radical treatment. In 2020, the suppressive treatment segment is dominating the malaria treatment market because it is considered to be the primary and fundamental treatment. Moreover, enormous demand of suppressive treatment worldwide acts as another driving factor for the malaria treatment market growth.
  • On the basis of drug type, the malaria treatment market is segmented into branded and generics. In 2020, generics segment is dominating the malaria treatment market because it is cost-effective in comparison to the branded drugs.
  • On the basis of route of administration, the malaria treatment market is segmented into oral and parenteral. Parenteral are is further subdivided into intravenous, intramuscular, and subcutaneous. In 2020, oral segment is dominating the malaria treatment market because it is considered to be the first line of therapy. Moreover, low manufacturing cost of tablets, capsules and other orally administered drugs act as another driving factor for the malaria treatment market growth.
  • On the basis of end user, the malaria treatment market is segmented into hospitals, specialty clinics, home healthcare and others. In 2020, hospitals segment is dominating the malaria treatment market because of the increased healthcare expenditure by hospitals on advanced medical treatment.
  • On the basis of distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies and online pharmacies. In 2020, direct tender segment is dominating the malaria treatment market because direct tender holds the largest market share along with the highest CAGR because most of the service providers buy the product from manufacturers, and it is noticed that revenue from direct sales is higher; so it is influential as well as growing in the malaria treatment market.

Malaria Treatment Market Country Level Analysis

Malaria treatment market is analysed and market size information is provided on the basis of country, agent, type, treatment type, drug type, route of administration, end user and distribution channel as referenced above.

The countries covered in malaria treatment market report are China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Vietnam, and Rest of Asia-Pacific.

Asia-Pacific is expected to grow with the fastest CAGR in the forecast period as the demand for malaria treatment are increasing very rapidly owing growing healthcare expenditure and increasing awareness regarding the malaria vector-borne disease symptoms. India is expected to dominate in the market in the Asia-Pacific malaria treatment market. Indonesia is one of the leading countries in the Asia-Pacific with increasing demand for malaria treatment products.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by Manufactures is Creating New Opportunities for Players in the Malaria Treatment Market

The malaria treatment market also provides you with detailed market analysis for every country growth in malaria treatment industry with malaria treatment drugs sales, impact of advancement in the malaria treatment technology and changes in regulatory scenarios with their support for the malaria treatment market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Malaria Treatment Market Share Analysis

The malaria treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to malaria treatment market.

The major players covered in the report are Actiza Pharmaceutical Private Limited, AdvaCare Pharma, Amneal Pharmaceuticals LLC., Hikma Pharmaceuticals PLC, Ipca Laboratories Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Zydus Cadila, Cipla Inc., Bliss GVS Pharma Ltd., GeoVax, MMV, Novartis AG, Sumaya Biotech, Taj Pharmaceuticals Limited, VLP Therapeutics, OSIVAX, Lupin Pharmaceuticals, Inc. (a subsidiary of LUPIN), AJANTA PHARMA, Strides Pharma Science Limited, sanofi-aventis U.S. LLC (a subsidiary of Sanofi) among others and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the malaria treatment market.

For instance,

  • In August 2017, Novartis and Medicines for Malaria Venture (MMV) have declared a patient study for KAF156, the next generation of anti-inflammatory rheumatic compounds with the potential to treat drug-intolerant strains of the malaria parasite. The experiment has tested the activity of KAF156 together with a new, improved combination of existing anti-malarial malaria cases.
  • In July 2017, Medicines for Malaria Venture (MMV) and Cipla Ltd. declared the launch of Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS) 100 mg. However, this product utilized for the management of severe malaria in young children and for life saving. This product launch has escalated the company revenue growth.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the malaria treatment market which also provides the benefit for organisation to improve their offering for malaria treatment market.

Customization Available: Asia-Pacific Malaria Treatment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 ASIA-PACIFIC MALARIA TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 3 ESTIMATED MALARIA CASES AND DEATHS BY REGION, 2018

TABLE 4 FUTURE VECTOR CARE - FUTURE GENERALI (MALARIA CARE FAMILY HEALTH PLAN)

TABLE 5 REGULATORY CHALLENGES TO ANTIMALARIAL DRUG APPROVAL.

TABLE 6 CHALLENGES AND PROBLEMS THAT DRIVE THE R&D FRAMEWORK

TABLE 7 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY AGENT 2019-2027 (USD THOUSAND)

TABLE 8 ASIA-PACIFIC PLASMODIUM FALCIPARUM IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 9 ASIA-PACIFIC P. VIVAX IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 10 ASIA-PACIFIC P. OVALE IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 11 ASIA-PACIFIC P. MALARIAE IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 12 ASIA-PACIFIC P. KNOWLELSI IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)

TABLE 13 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TYPE 2019-2027 (USD THOUSAND)

TABLE 14 ASIA-PACIFIC MEDICATION IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 15 ASIA-PACIFIC MEDICATION IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 16 ASIA-PACIFIC ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 17 ASIA-PACIFIC NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 18 ASIA-PACIFIC VACCINE IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 19 ASIA-PACIFIC VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 20 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TREATMENT TYPE 2019-2027 (USD THOUSAND)

TABLE 21 ASIA-PACIFIC SUPPRESSIVE TREATMENT IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 22 ASIA-PACIFIC RADICAL TREATMENT IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 23 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DRUG TYPE 2019-2027 (USD THOUSAND)

TABLE 24 ASIA-PACIFIC GENERICS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 25 ASIA-PACIFIC BRANDED IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 26 ASIA-PACIFIC BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 27 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2019-2027 (USD THOUSAND)

TABLE 28 ASIA-PACIFIC ORAL IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 29 ASIA-PACIFIC PARENTERAL IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 30 ASIA-PACIFIC PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 31 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY END USER 2019-2027 (USD THOUSAND)

TABLE 32 ASIA-PACIFIC HOSPITALS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 33 ASIA-PACIFIC SPECIALTY CLINICS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 34 ASIA-PACIFIC HOME HEALTHCARE IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 35 ASIA-PACIFIC OTHERS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 36 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2027 (USD THOUSAND)

TABLE 37 ASIA-PACIFIC DIRECT TENDER IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)

TABLE 38 ASIA-PACIFIC HOSPITAL PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 39 ASIA-PACIFIC RETAIL PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 40 ASIA-PACIFIC ONLINE PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)

TABLE 41 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY REGION 2018-2027 (USD THOUSAND)

TABLE 42 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 43 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 44 ASIA-PACIFIC MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 45 ASIA-PACIFIC ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 46 ASIA-PACIFIC NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 47 ASIA-PACIFIC VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 48 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 49 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 50 ASIA-PACIFIC BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 51 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 52 ASIA-PACIFIC PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 53 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 54 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 55 INDIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 56 INDIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 57 INDIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 58 INDIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 59 INDIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 60 INDIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 61 INDIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 62 INDIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 63 INDIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 64 INDIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 65 INDIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 66 INDIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 67 INDIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 68 INDONESIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 69 INDONESIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 70 INDONESIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 71 INDONESIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 72 INDONESIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 73 INDONESIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 74 INDONESIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 75 INDONESIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 76 INDONESIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 77 INDONESIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 78 INDONESIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 79 INDONESIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 80 INDONESIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 81 SOUTH KOREA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 82 SOUTH KOREA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 83 SOUTH KOREA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 84 SOUTH KOREA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 85 SOUTH KOREA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 86 SOUTH KOREA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 87 SOUTH KOREA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 88 SOUTH KOREA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 89 SOUTH KOREA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 90 SOUTH KOREA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 91 SOUTH KOREA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 92 SOUTH KOREA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 93 SOUTH KOREA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 94 THAILAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 95 THAILAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 96 THAILAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 97 THAILAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 98 THAILAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 99 THAILAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 100 THAILAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 101 THAILAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 102 THAILAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 103 THAILAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 104 THAILAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 105 THAILAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 106 THAILAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 107 PHILIPPINES MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 108 PHILIPPINES MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 109 PHILIPPINES MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 110 PHILIPPINES ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 111 PHILIPPINES NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 112 PHILIPPINES VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 113 PHILIPPINES MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 114 PHILIPPINES MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 115 PHILIPPINES BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 116 PHILIPPINES MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 117 PHILIPPINES PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 118 PHILIPPINES MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 119 PHILIPPINES MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 120 VIETNAM MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 121 VIETNAM MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 122 VIETNAM MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 123 VIETNAM ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 124 VIETNAM NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 125 VIETNAM VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 126 VIETNAM MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 127 VIETNAM MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 128 VIETNAM BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 129 VIETNAM MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 130 VIETNAM PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 131 VIETNAM MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 132 VIETNAM MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 133 JAPAN MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 134 JAPAN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 135 JAPAN MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 136 JAPAN ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 137 JAPAN NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 138 JAPAN VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 139 JAPAN MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 140 JAPAN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 141 JAPAN BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 142 JAPAN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 143 JAPAN PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 144 JAPAN MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 145 JAPAN MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 146 AUSTRALIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 147 AUSTRALIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 148 AUSTRALIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 149 AUSTRALIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 150 AUSTRALIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 151 AUSTRALIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 152 AUSTRALIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 153 AUSTRALIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 154 AUSTRALIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 155 AUSTRALIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 156 AUSTRALIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 157 AUSTRALIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 158 AUSTRALIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 159 SINGAPORE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 160 SINGAPORE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 161 SINGAPORE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 162 SINGAPORE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 163 SINGAPORE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 164 SINGAPORE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 165 SINGAPORE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 166 SINGAPORE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 167 SINGAPORE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 168 SINGAPORE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 169 SINGAPORE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 170 SINGAPORE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 171 SINGAPORE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 172 CHINA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 173 CHINA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 174 CHINA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 175 CHINA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 176 CHINA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 177 CHINA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 178 CHINA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 179 CHINA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 180 CHINA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 181 CHINA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 182 CHINA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 183 CHINA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 184 CHINA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 185 MALAYSIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

TABLE 186 MALAYSIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 187 MALAYSIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 188 MALAYSIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 189 MALAYSIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 190 MALAYSIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)

TABLE 191 MALAYSIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)

TABLE 192 MALAYSIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 193 MALAYSIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)

TABLE 194 MALAYSIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 195 MALAYSIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)

TABLE 196 MALAYSIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)

TABLE 197 MALAYSIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

TABLE 198 REST OF ASIA-PACIFIC MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions